Taysha Gene Therapies
TSHA
TSHA
191 hedge funds and large institutions have $1.21B invested in Taysha Gene Therapies in 2026 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
5.73% less ownership
Funds ownership: 98.2% → 92.47% (-5.7%)
19% less capital invested
Capital invested by funds: $1.48B → $1.21B (-$274M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
191
Holding in Top 10
3
Calls
$1.61M
Puts
$354K
Top Buyers
| 1 | +$40.3M | |
| 2 | +$19.8M | |
| 3 | +$8.14M | |
| 4 |
SG Americas Securities
New York
|
+$6.49M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.69M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$12.7M | |
| 3 | -$12.6M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$10.7M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$10.6M |
